Lou Iovino

  • Citations Per Year
Learn More
INTRODUCTION Nonoperative treatment of stage III non-small cell lung cancer has evolved over the past 30 years. The current approach in the Unites States most often includes concurrent chemoradiotherapy. METHODS We have used live, case-based research events to document prescribing plans among American medical oncologists for first-line therapy in patients(More)
e19046 Background: Selection of oral EGFR inhibitors or chemotherapy as 2nd line in patients with NSCLC may be influenced by patients' performance status (PS), smoking status, gender; tumor histology; tolerance/response to 1st-line Rx; and patient expectations/desires. METHODS Between February '07 and October '08, we used a core case scenario of stage IV(More)
  • 1